Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced financial results for the first quarter ended March 31, 2025 and outlined operational highlights ...

Max will become HBO Max again this summer, Warner Bros. Discovery said this week — two years after the name change that ...

Max will become HBO Max again this summer, Warner Bros. Discovery said this week — two years after the name change that ...

Male actors are redefining the idea of machismo by showcasing their real-life, tender, vulnerable, sensitive side, and the ...

The Novartis oncology strategy focuses on people living with cancer and those who care for them, from loved ones to clinical care teams, including their providers. For the past 30+ years, the aim has ...

ADC Therapeutics SA (NYSE: ADCT) Q1 2025 Earnings Call Transcript May 14, 2025 ADC Therapeutics SA beats earnings ...

India recently pulled a Paul Heyman on Pakistan turned heel. As a consequence, all Pakistani celebrities who ever worked in ...

There’s a storm brewing on Kenyan X, and it’s not about the usual chaos. This time it’s about AFTV — the world-famous, meme-generating, fan-driven Arsenal ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of ...

Twenty One Capital made headlines by acquiring 4,812 BTC for $458.7 million at an average price of $95,300 per Bitcoin.

Total revenues for Q1 2025 were reported as $8.7M, down from $12.1M in Q1 2024. Manufacturer and supply revenue decreased to $7.2M, driven by a decline in Suboxone, partially offset by Ondif gains.